
Opinion|Videos|April 30, 2024
Key Barriers in Implementing Guideline-Directed Cholesterol Treatment
Clinical pharmacists discuss how to address key barriers that get in the way of implementing guideline-directed cholesterol treatment.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Apitegromab-mstn, First Muscle-Targeted SMA Therapy
2
Predictive Models Could Address Missing Data in Advanced Prostate Cancer
3
Pharmacists Can Close the LDL Control Gap in Lipid Care
4
Ivonescimab Significantly Extends OS Over Pembrolizumab in PD-L1-Positive Advanced NSCLC
5





































































































